Junko Yarimizu

A Comparative Study on the Hydroperoxide and Thiol Specificity of the Glutathione Peroxidase Family and Selenoprotein P

Gen Takebe, Junko Yarimizu, Yoshiro Saito et al. · Journal of Biological Chemistry · 2002 · 316 citations · Full text

Life Sciences, Biochemistry, Cellular Biochemistry +14

Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice

Yasuyuki Mitani, Junko Yarimizu, Kyoko Saita et al. · Journal of Neuroscience · 2012 · 196 citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia

Mitsuyuki Matsumoto, Richard E. Straub, Stefano Marenco et al. · Proceedings of the National Academy of Sciences · 2008 · 82 citations · Full text

Life Sciences, Genetics, Neuroscience +15

Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1 H)-one (ASP5854), in Models of Parkinson’s Disease and Cognition

Takuma Mihara, Kayoko Mihara, Junko Yarimizu et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 76 citations

Medicine, Neuroscience, Pharmacology +11

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease

Katsuya Harada, Kazuhiro Nakato, Junko Yarimizu et al. · European Journal of Pharmacology · 2012 · 61 citations

Medicine, Neuroscience, Pharmacology +12